ResearchIn-Press PreviewAIDS/HIVImmunologyInfectious disease
Open Access |
10.1172/jci.insight.201268
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Cronin, S. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Simpson, J. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Pereyra-Casanova, A. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Li, Y. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Marín-Rojas, J. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Warner van Dijk, F. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Fisher, K. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Buffa, D. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Rana, H. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Vahlas, Z. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Barros, J. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Maio, M. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by O'Neil, T. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Bertram, K. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Lee, E. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Nasr, N. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by
Harman, A.
in:
PubMed
|
Google Scholar
|
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Turk, G. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by
Quiroga, M.
in:
PubMed
|
Google Scholar
|
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Kelleher, A. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Vérollet, C. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Balboa, L. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by Palmer, S. in: PubMed | Google Scholar
1Centre for Virus Research, The Westmead Institute for Medical Research, Sydney, Australia
2Centre for Virus Research, The Wesmtead Institute for Medical Research, Sydney, Australia
3Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS. Université Toulouse III - Paul Sabatier (UT3), Toulouse, France
4Departamento de Microbiología, Parasitología e Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina
5Centre for Virus Research, The Westmead Institute for Medical Research, Australia
6Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia
7The Kirby Institute, University of New South Wales, Sydney, Australia
8Mécanismes Moléculaires des Infections Mycobactériennes, CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse, France
Find articles by
Duette, G.
in:
PubMed
|
Google Scholar
|
Published August 20, 2026 - More info
Mycobacteriumtuberculosis (Mtb), the causative agent of tuberculosis (TB), is the most common coinfection in people living with HIV-1 (PLWH). This coinfection is associated with accelerated HIV-1 disease progression and reduced survival. However, the immunological and virological mechanisms driving this progression are not completely understood. To address this knowledge gap, using pleural effusion samples from PLWH and TB, we investigated how the HIV-1 genetic landscape and the anti-HIV-1 immune response are impacted by a TB-associated microenvironment. Our results revealed an enrichment of genetically intact HIV-1 and impaired CD8+ T cell-mediated antiviral response at this site of HIV-1/Mtb coinfection. Moreover, efficient CD8+ T cell activation was inhibited by lipids present in the TB-associated pleural effusion. These findings indicate that this immune microenvironment induced by TB promotes the persistence of cells infected with replication-competent HIV-1 by creating a niche of reduced antiviral immune pressure, potentially contributing to the worsened clinical outcomes observed in PLWH and TB.